Pharmacology Flashcards
Graded dose response curve
Y- effect
X- drug concentration
EC50- concentration at 50% effect
ligand receptor binding curve
Y- DR bound
X- Drug concentration
Kd = concentration at 50% binding
Quantal dose response curve
Y- % individual responding
X- dose
graph ED50, TD50, LD50
Therapeutic index
=TD50/ED50 (bigger is better)
Margin of safety
LD1/ED99 (bigger is better)
Receptor effector coupling
transduction process between binding and effect (full–>partial–>antagonist)
Categorize competitive vs noncompetitive antagonists
Allosteric (reversible/irreversible) = noncompetitive
Active (orthosteric) irreversible = noncompetitive
Active reversible = competitive
Effect of competitive antagonist on agonist
decrease potency
Effect of noncompetitive antagonist on agonist
Decreased efficacy
noncompetitive antagonist effect on agonist WITH spare receptors
first as competitive (decrease potency)
then act as noncompetitive (decrease efficacy)
Why allosteric ligand drugs are cool.
- ceiling effect(limit with all sites bound)
- selective for tissue with endogenous active
- subtype selectivity (more varietytoo)
tachyphylaxis
repeat same dose–> decreased effect
Desensitization:
decreased receptor ability to response (homologous vs heterologous)
Inactivation:
loss of receptor ability to respond
downregulation
receptor removal from repeated stim